1433362-83-4

Upstream product

• 611-19-8 1-chloro-2-(chloromethyl)benzene 
• 93444-91-8 5-amino-1-(2-chlorobenzyl)-1H-1,2,3-triazole-4-carboxamide 
• 1433363-02-0 1-(2-chlorobenzyl)-5-pivalamido-1H-1,2,3-triazole-4-carboxamide 
• 1433363-04-2 N-(1-(2-chlorobenzyl)-4-cyano-1H-1,2,3-triazol-5-yl)pivalamide 
• 611-17-6 1-bromomethyl-2-chlorobenzene 
• 3282-30-2 pivaloyl chloride 
• 63777-70-8 2-chlorobenzylazide 

Downstream Products

• 1433357-83-5 (S)-1-[5-tert-butyl-3-(2-chloro-benzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl]-pyrrolidin-3-ol 
• 1433358-67-8 5-tert-butyl-3-(2-chloro-benzyl)-7-(1,1-dioxo-1λ⁶-isothiazolidin-2-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine 
• 1433362-10-7 5-tert-butyl-3-(2-chloro-benzyl)-7-cyclobutoxy-3H-[1,2,3]triazolo[4,5-d]pyrimidine 
• 841214-38-8 3-[(2-chlorophenyl)methyl]-5-(1,1-dimethylethyl)-7-(4-morpholinyl)-3H-1,2,3-triazolo[4,5-d]pyrimidine 

Relevant academic research and scientific papers

TRIAZOLO[4,5-D]PYRIMIDINES AS AGONISTS OF THE CANNABINOID RECEPTOR 2

The invention relates to a compound of formula (I) wherein R1to R4and n are defined as in the description and in the claims. The present invention relates to organic compounds useful for therapy and/or prophylaxis in a mammal, and in

[1, 2, 3] TRIAZOLO [4, 5 -D] PYRIMIDINE DERIVATIVES AS AGONISTS OF THE CANNABINOID RECEPTOR 2

The invention relates to a compound of formula (I), wherein A, R1 and R2 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament as agonists of the cannabinoid receptor 2.

NOVEL [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein A, R1 and R2 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.